EBAMed: EBAMed completes Series A with EUR 1.6M investment

EBAMed, a Geneva-based company developing a guidance system for the non-invasive treatment of heart arrhythmias through Proton Therapy, has just secured a further EUR 1.6M from CDP Venture Capital and the European Union. This brings the total amount raised in the series A financing round to EUR 16M.